We are live on ! Find out more
KDNY

Chinook Therapeutics, Inc. Common Stock
KDNY

Delisted

KDNY was delisted on the 10th of August, 2023.

Back to rankings

157 hedge funds and large institutions have $1.42B invested in Chinook Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 57 increasing their positions, 49 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

460% more call options, than puts

Call options by funds: $5.61M | Put options by funds: $1M

25% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 16

16% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 49

1% more funds holding

Funds holding: 155 → 157 (+2)

5% less capital invested

Capital invested by funds: $1.49B → $1.42B (-$67.2M)

25% less funds holding in top 10

Funds holding in top 10: 8 → 6 (-2)

Holders
157
Holders Change
+2
Holders Change %
+1.29%
% of All Funds
2.5%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.1%
New
20
Increased
57
Reduced
49
Closed
16
Calls
$5.61M
Puts
$1M
Net Calls
+$4.61M
Net Calls Change
+$3.95M

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$31.3M
2
EAM
Eventide Asset Management
Massachusetts
+$25.5M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$21.1M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$11.5M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$8.68M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$25.7M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$12.8M
3
Citadel Advisors
Citadel Advisors
Florida
-$9.51M
4
EC
EcoR1 Capital
California
-$5.83M
5
Millennium Management
Millennium Management
New York
-$4.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
51
Bank of New York Mellon
New York
$4.52M -$613K -25,707 -12%
Rafferty Asset Management
52
Rafferty Asset Management
New York
$4.19M +$168K +7,063 +4%
PI
53
Putnam Investments
Massachusetts
$4.17M -$71.5K -3,000 -2%
PCH
54
Polar Capital Holdings
United Kingdom
$4.05M +$4.17M +175,000 New
Connor, Clark & Lunn Investment Management (CC&L)
55
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$3.94M -$1.56M -65,605 -28%
JP Morgan Chase
56
JP Morgan Chase
New York
$3.66M +$143K +5,979 +4%
Two Sigma Investments
57
Two Sigma Investments
New York
$3.57M +$373K +15,637 +11%
SG Americas Securities
58
SG Americas Securities
New York
$3.56M +$3.48M +145,861 +1,818%
IHAM
59
Integral Health Asset Management
New York
$3.52M -$548K -23,000 -13%
PAMP
60
Polar Asset Management Partners
Ontario, Canada
$3.46M – – –
Citigroup
61
Citigroup
New York
$3.42M +$1.66M +69,615 +89%
AG
62
Algert Global
California
$3.16M +$117K +4,889 +4%
CA
63
CHI Advisors
New York
$3.13M +$3.22M +135,000 New
Renaissance Technologies
64
Renaissance Technologies
New York
$2.7M -$1.55M -65,100 -36%
NFGH
65
Nan Fung Group Holdings
Hong Kong
$2.64M – – –
Citadel Advisors
66
Citadel Advisors
Florida
$2.6M -$9.51M -398,986 -78%
SFM
67
Sphera Funds Management
Israel
$2.13M -$834K -35,000 -28%
Swiss National Bank
68
Swiss National Bank
Switzerland
$2.08M -$215K -9,000 -9%
Barclays
69
Barclays
United Kingdom
$1.94M -$429K -18,016 -18%
TCM
70
Tekla Capital Management
Massachusetts
$1.93M +$1.99M +83,500 New
RhumbLine Advisers
71
RhumbLine Advisers
Massachusetts
$1.89M +$16.2K +678 +0.8%
Susquehanna International Group
72
Susquehanna International Group
Pennsylvania
$1.82M +$1.23M +51,432 +189%
UBS Group
73
UBS Group
Switzerland
$1.78M +$196K +8,224 +12%
Hudson Bay Capital Management
74
Hudson Bay Capital Management
Connecticut
$1.43M +$1.47M +61,611 New
New York State Common Retirement Fund
75
New York State Common Retirement Fund
New York
$1.35M -$279K -11,695 -17%
1 2
3
4 5

KDNY Hedge Fund Activity: Q1 2023 in Review

157 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Chinook Therapeutics, Inc. Common Stock (KDNY) for Q1 2023, worth a combined $1.42B — down 4.5% from $1.49B a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new KDNY positions and 16 closed out — a net gain of 4 holders — while 57 added to existing stakes and 49 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $31.3M. The largest seller was Baker Bros. Advisors, cutting an estimated $25.7M.

  • 157 institutional investors held Chinook Therapeutics, Inc. Common Stock (KDNY) as of Q1 2023, up from 155 in Q4 2022.
  • Funds reported $1.42B of Chinook Therapeutics, Inc. Common Stock stock for Q1 2023, down 4.5% quarter-over-quarter.
  • 20 funds opened new Chinook Therapeutics, Inc. Common Stock positions in Q1 2023 and 16 closed out, a net change of +4 holders.
  • The largest Chinook Therapeutics, Inc. Common Stock buyer in Q1 2023 was Franklin Resources, an estimated $31.3M added.
  • The largest Chinook Therapeutics, Inc. Common Stock seller in Q1 2023 was Baker Bros. Advisors, an estimated $25.7M sold.

Based on aggregated 13F filings for Q1 2023.